These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2005934

  • 1. Sickness due to levodopa-induced neck dyskinesias in Parkinson's disease.
    Steiger MJ, Quinn NP, Marsden CD.
    Mov Disord; 1991; 6(1):91-2. PubMed ID: 2005934
    [No Abstract] [Full Text] [Related]

  • 2. Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Zimmerman TR, Sage JI, Lang AE, Mark MH.
    Mov Disord; 1994 Mar; 9(2):173-7. PubMed ID: 8196678
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Motor complications in patients with Parkinson disease treated with levodopa].
    Luquin MR, Obeso JA, Martínez-Lage JM.
    Neurologia; 1989 Mar; 4(1):4-11. PubMed ID: 2631806
    [Abstract] [Full Text] [Related]

  • 5. Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction.
    Bennett JP, Landow ER, Dietrich S, Schuh LA.
    Mov Disord; 1994 Jul; 9(4):409-14. PubMed ID: 7969207
    [Abstract] [Full Text] [Related]

  • 6. The effects of combining carbidopa with levodopa for Parkinson's disease.
    Martin WE, Tolosa ES, Loewenson RB, Lee MC, Resch JA, Baker AB.
    Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406
    [No Abstract] [Full Text] [Related]

  • 7. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Arnold G, Trenkwalder C, Schwarz J, Oertel WH.
    Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ocular dyskinesias in patients with Parkinson's disease treated with levodopa.
    Shimizu N, Cohen B, Bala SP, Mendoza M, Yahr MD.
    Ann Neurol; 1977 Feb; 1(2):167-71. PubMed ID: 889300
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Body weight, levodopa pharmacokinetics and dyskinesia in Parkinson's disease.
    Arabia G, Zappia M, Bosco D, Crescibene L, Bagalà A, Bastone L, Caracciolo M, Scornaienghi M, Quattrone A.
    Neurol Sci; 2002 Sep; 23 Suppl 2():S53-4. PubMed ID: 12548340
    [Abstract] [Full Text] [Related]

  • 13. L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
    Rascol O.
    Mov Disord; 1999 Sep; 14 Suppl 1():19-32. PubMed ID: 10493400
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. L-dopa induced dyskinesias in asymmetrical parkinsonism.
    Murphy MJ.
    Acta Neurol Latinoam; 1979 Sep; 25(1-2):47-52. PubMed ID: 583384
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Motor complications of Parkinson's disease.
    Martignoni E, Riboldazzi G, Calandrella D, Riva N.
    Neurol Sci; 2003 May; 24 Suppl 1():S27-9. PubMed ID: 12774208
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dyskinesias predict the onset of motor response fluctuations in patients with Parkinson's disease on L-dopa monotherapy.
    Mazzella L, Yahr MD, Marinelli L, Huang N, Moshier E, Di Rocco A.
    Parkinsonism Relat Disord; 2005 May; 11(3):151-5. PubMed ID: 15823479
    [Abstract] [Full Text] [Related]

  • 20. Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatments.
    Encarnacion EV, Hauser RA.
    Eur Neurol; 2008 May; 60(2):57-66. PubMed ID: 18480609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.